Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.250
-0.110 (-4.66%)
At close: Jul 20, 2026, 4:00 PM EDT
2.340
+0.090 (4.00%)
After-hours: Jul 20, 2026, 7:34 PM EDT
Pyxis Oncology Revenue
Pyxis Oncology had revenue of $13.86M in the twelve months ending March 31, 2026. In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%.
Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
10.29
Revenue / Employee
$247,464
Employees
56
Market Cap
142.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.86M | -2.29M | -14.17% |
| Dec 31, 2024 | 16.15M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 32.73M |
| Cibus | 4.29M |
| Camp4 Therapeutics | 3.93M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 233.00K |
PYXS News
- 20 days ago - Pyxis Oncology announces up to $114M private placement - TheFly
- 20 days ago - Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones - GlobeNewsWire
- 6 weeks ago - Pyxis Oncology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Pyxis Oncology Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 2 months ago - Pyxis Oncology Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Pyxis Oncologyreports Q1 EPS (37c), consensus (35c) - TheFly
- 2 months ago - Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones - GlobeNewsWire
- 2 months ago - Pyxis Oncology Quarterly report: Q1 2026 - Filings